Copyright
©The Author(s) 2024.
Artif Intell Gastrointest Endosc. Jun 8, 2024; 5(2): 90704
Published online Jun 8, 2024. doi: 10.37126/aige.v5.i2.90704
Published online Jun 8, 2024. doi: 10.37126/aige.v5.i2.90704
Esophageal cancer | Lesion characterization (Barrett's esophagus vs dysplasia vs ESCC[7-9] |
Predicting histological response to therapy[30-32] | |
Prognostic assessment[33-37] | |
Gastric cancer | Endoscopic detection of early GC[44-46] |
Differentiation between stage IV GC and PGL[48,49] | |
Accurate TNM staging[54-57] | |
Colon cancer | Higher adenoma detection, reduced neoplasia“miss rate"[72-74] |
Superior LNM estimation[81-85] | |
Intraoperative guidance during colorectal resection[92-95] |
- Citation: Bangolo A, Wadhwani N, Nagesh VK, Dey S, Tran HHV, Aguilar IK, Auda A, Sidiqui A, Menon A, Daoud D, Liu J, Pulipaka SP, George B, Furman F, Khan N, Plumptre A, Sekhon I, Lo A, Weissman S. Impact of artificial intelligence in the management of esophageal, gastric and colorectal malignancies. Artif Intell Gastrointest Endosc 2024; 5(2): 90704
- URL: https://www.wjgnet.com/2689-7164/full/v5/i2/90704.htm
- DOI: https://dx.doi.org/10.37126/aige.v5.i2.90704